Variant report

Variant	esv3421605
Chromosome Location	chr21:45992974-45995472
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:144)
CpG islands
(count:122)
Chromatin interactive
region (count:3)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:144 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr21:45993004-45993077	K562	blood:	n/a	n/a
2	BHLHE40	chr21:45993089-45993414	HepG2	liver:	n/a	n/a
3	BHLHE40	chr21:45993089-45993220	K562	blood:	n/a	n/a
4	CEBPB	chr21:45992965-45993094	HepG2	liver:	n/a	n/a
5	CEBPB	chr21:45994898-45995082	HepG2	liver:	n/a	n/a
6	CHD2	chr21:45994914-45995251	HepG2	liver:	n/a	chr21:45995063-45995073
7	CTCF	chr21:45994003-45994027	LNCaP	prostate:	n/a	n/a
8	CTCF	chr21:45994300-45994450	GM12874	blood:	n/a	n/a
9	CTCF	chr21:45994007-45994085	NHEK	skin:	n/a	n/a
10	CTCF	chr21:45994228-45994332	MCF-7	breast:	n/a	n/a
11	CTCF	chr21:45994353-45994644	MCF-7	breast:	n/a	n/a
12	CTCF	chr21:45994160-45994220	GM13977	blood:	n/a	n/a
13	CTCF	chr21:45994500-45994650	HEK293	kidney:	n/a	n/a
14	CTCF	chr21:45994380-45994530	SK-N-SH_RA	brain:	n/a	n/a
15	CTCF	chr21:45994360-45994510	Hela-S3	cervix:	n/a	n/a
16	CTCF	chr21:45994001-45994075	Spleen_OC	spleen:	n/a	n/a
17	CTCF	chr21:45994357-45994497	MCF-7	breast:	n/a	n/a
18	CTCF	chr21:45994320-45994470	GM12872	blood:	n/a	n/a
19	CTCF	chr21:45994355-45994381	GM19239	blood:	n/a	n/a
20	CTCF	chr21:45994066-45994330	K562	blood:	n/a	n/a
21	CTCF	chr21:45994852-45994878	H1-hESC	embryonic stem cell:	n/a	n/a
22	CTCF	chr21:45994233-45994308	K562	blood:	n/a	n/a
23	CTCF	chr21:45994340-45994490	GM12867	blood:	n/a	n/a
24	CTCF	chr21:45994320-45994470	GM12867	blood:	n/a	n/a
25	CTCF	chr21:45994340-45994490	GM12873	blood:	n/a	n/a
26	CTCF	chr21:45994220-45994370	HCT-116	colon:	n/a	n/a
27	CTCF	chr21:45993986-45994189	Lung_OC	lung:	n/a	n/a
28	CTCF	chr21:45993998-45994497	K562	blood:	n/a	n/a
29	CTCF	chr21:45994338-45994402	Medullo	brain:	n/a	n/a
30	CTCF	chr21:45995160-45995310	A549	lung:	n/a	n/a
31	CTCF	chr21:45994360-45994510	HBMEC	blood vessel:	n/a	n/a
32	CTCF	chr21:45994546-45994631	Fibrobl	skin:	n/a	n/a
33	CTCF	chr21:45994276-45994494	Hela-S3	cervix:	n/a	n/a
34	CTCF	chr21:45994380-45994530	HCFaa	heart:	n/a	n/a
35	CTCF	chr21:45994300-45994450	GM12872	blood:	n/a	n/a
36	CTCF	chr21:45994482-45994494	A549	lung:	n/a	n/a
37	CTCF	chr21:45994360-45994510	GM12865	blood:	n/a	n/a
38	CTCF	chr21:45994213-45994309	H1-hESC	embryonic stem cell:	n/a	n/a
39	CTCF	chr21:45994520-45994670	GM12872	blood:	n/a	n/a
40	CTCF	chr21:45994326-45994557	H1-hESC	embryonic stem cell:	n/a	n/a
41	CTCF	chr21:45994219-45994523	Fibrobl	skin:	n/a	n/a
42	CTCF	chr21:45994340-45994490	GM12864	blood:	n/a	n/a
43	CTCF	chr21:45994400-45994550	NB4	blood:	n/a	n/a
44	CTCF	chr21:45994440-45994590	SK-N-SH_RA	brain:	n/a	n/a
45	CTCF	chr21:45994300-45994450	HMEC	breast:	n/a	n/a
46	CTCF	chr21:45994340-45994490	K562	blood:	n/a	n/a
47	CTCF	chr21:45993989-45994232	LNCaP	prostate:	n/a	n/a
48	CTCF	chr21:45994360-45994510	NHEK	skin:	n/a	n/a
49	CTCF	chr21:45994440-45994590	GM12865	blood:	n/a	n/a
50	CTCF	chr21:45994400-45994550	GM12866	blood:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr21:45994842-45994892	HPAEpiC	pulmonary alveolar:	n/a
2	chr21:45994842-45994892	PANC-1	pancreas:	n/a
3	chr21:45994842-45994892	SK-N-SH_RA	brain:	n/a
4	chr21:45994842-45994892	HMEC	breast:	n/a
5	chr21:45993280-45993330	AoSMC	blood vessel:	n/a
6	chr21:45993280-45993330	SKMC	muscle:	n/a
7	chr21:45993280-45993330	HRPEpiC	eye:	n/a
8	chr21:45993280-45993330	SK-N-MC	brain:	n/a
9	chr21:45994842-45994892	MCF-7	breast:	n/a
10	chr21:45993280-45993330	HepG2	liver:	n/a
11	chr21:45994842-45994892	Jurkat	blood:	n/a
12	chr21:45994842-45994892	AG04450	lung:	fetal
13	chr21:45993280-45993330	ovcar-3	ovarian:	n/a
14	chr21:45993280-45993330	HUVEC	blood vessel:	n/a
15	chr21:45993280-45993330	HEK293	kidney:	embryo
16	chr21:45993280-45993330	LNCaP	prostate:	n/a
17	chr21:45993280-45993330	HAEpiC	amniotic membrane:	n/a
18	chr21:45993280-45993330	MCF-7	breast:	n/a
19	chr21:45994842-45994892	HL-60	blood:	n/a
20	chr21:45994842-45994892	SK-N-SH	brain:	n/a
21	chr21:45993280-45993330	GM12892	blood:	n/a
22	chr21:45993280-45993330	IMR90	lung:	fetal
23	chr21:45993280-45993330	RPTEC	kidney:	n/a
24	chr21:45994842-45994892	ECC-1	luminal epithelium:	n/a
25	chr21:45994842-45994892	GM12891	blood:	n/a
26	chr21:45993280-45993330	T-47D	breast:	n/a
27	chr21:45993280-45993330	MCF10A-Er-Src	breast:	n/a
28	chr21:45994842-45994892	NB4	blood:	n/a
29	chr21:45994842-45994892	Hela-S3	cervix:	n/a
30	chr21:45993280-45993330	HL-60	blood:	n/a
31	chr21:45993280-45993330	AG09309	skin:	n/a
32	chr21:45994842-45994892	MCF10A-Er-Src	breast:	n/a
33	chr21:45993280-45993330	AG04450	lung:	fetal
34	chr21:45994842-45994892	SK-N-MC	brain:	n/a
35	chr21:45993280-45993330	HEEpiC	esophagus:	n/a
36	chr21:45994842-45994892	HNPCEpiC	eye:	n/a
37	chr21:45993280-45993330	PrEC	prostate:	n/a
38	chr21:45993280-45993330	K562	blood:	n/a
39	chr21:45994842-45994892	HEEpiC	esophagus:	n/a
40	chr21:45994842-45994892	HAEpiC	amniotic membrane:	n/a
41	chr21:45993280-45993330	NHDF-neo	bronchial:	n/a
42	chr21:45994842-45994892	NH-A	brain:	n/a
43	chr21:45993280-45993330	CMK	blood:	n/a
44	chr21:45994842-45994892	Hepatocyte	liver:	n/a
45	chr21:45994842-45994892	H1-hESC	embryonic stem cell:	embryo
46	chr21:45994842-45994892	AG10803	skin:	n/a
47	chr21:45993280-45993330	Hela-S3	cervix:	n/a
48	chr21:45993280-45993330	A549	lung:	n/a
49	chr21:45994842-45994892	HRPEpiC	eye:	n/a
50	chr21:45993280-45993330	SAEC	small airway:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr21:45989841..45993258-chr21:45994452..45997591,3	MCF-7	breast:
2	chr21:45989841..45993258-chr21:45994452..45997591,3	MCF-7	breast:
3	chr21:45947897..45950026-chr21:45993818..45996487,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KRTAP10-4-1	chr21:45994970-45995428	NONHSAT082869

No data

Variant related genes	Relation type
TSPEAR	TF binding region
KRTAP10-4	TF binding region
TSPEAR	CpG island
KRTAP10-4	CpG island

Extended variants
information (count: 208 )
Associated
traits (count: 102 )

Variant overlapped rSNPs/rCNVs (count:208 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs587641747	chr21:45992977-45992978	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs587723342	chr21:45993004-45993005	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs185232335	chr21:45993053-45993054	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs9985041	chr21:45993061-45993062	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
5	rs73907030	chr21:45993075-45993076	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs2838592	chr21:45993131-45993132	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
7	rs150235533	chr21:45993149-45993150	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs587696042	chr21:45993159-45993160	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs9974056	chr21:45993170-45993171	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs386819173	chr21:45993181-45993182	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs9976765	chr21:45993182-45993183	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs9974066	chr21:45993195-45993196	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs116463992	chr21:45993209-45993210	Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs138914244	chr21:45993257-45993258	Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs9974403	chr21:45993259-45993260	Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs9976331	chr21:45993270-45993271	Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs587768232	chr21:45993280-45993281	Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs587619508	chr21:45993281-45993282	Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
19	rs372338693	chr21:45993289-45993290	Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
20	rs587701060	chr21:45993295-45993296	Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
21	rs147543723	chr21:45993311-45993312	Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
22	rs587625769	chr21:45993315-45993316	Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
23	rs114188093	chr21:45993345-45993346	Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs587739556	chr21:45993358-45993359	Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs587616331	chr21:45993361-45993362	Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs587697788	chr21:45993371-45993372	Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs201447603	chr21:45993374-45993375	Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs376218030	chr21:45993378-45993379	Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs587630462	chr21:45993445-45993446	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs587699877	chr21:45993462-45993463	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs587750714	chr21:45993536-45993537	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs138644786	chr21:45993538-45993539	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs113200827	chr21:45993544-45993545	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs371823582	chr21:45993552-45993553	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs59407182	chr21:45993561-45993562	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs199930733	chr21:45993562-45993563	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs587666169	chr21:45993578-45993579	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs587746174	chr21:45993586-45993587	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs200373178	chr21:45993591-45993592	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs199689212	chr21:45993613-45993614	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs200314238	chr21:45993622-45993623	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs368003811	chr21:45993623-45993624	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs371752955	chr21:45993626-45993627	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs587736322	chr21:45993629-45993630	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs587618128	chr21:45993631-45993632	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs367939631	chr21:45993635-45993636	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs371526320	chr21:45993641-45993642	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs375842508	chr21:45993642-45993643	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs368666574	chr21:45993653-45993654	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs9977039	chr21:45993666-45993667	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:102)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Down syndrome	17412756	CNVD
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Renal cell carcinoma	19461508	CNVD
Seminomas	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
lymphocytic leukemia	21291569	CNVD
Melanoma	18172304	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Wilms tumour	21544195	CNVD
Ewing''s sarcoma	17952124	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute myeloid leukemia	16864856	CNVD
Mental retardation	21031080	CNVD
Polymicrogyria	21031080	CNVD
periventricular nodular heterotopia	21031080	CNVD
Myelodysplastic syndrome	21606161	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Breast cancer	21858162	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17899364	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Glioblastoma multiforme	18628472	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Ewing''s sarcoma	21437220	CNVD
Lung adenocarcinoma	17086460	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute myeloid leukemia	21358987	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Prostate cancer	23341502	CNVD
Ovarian cancer	21720365	CNVD
Urothelial carcinoma	21177765	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	21251322	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Cholangiocarcinoma	16830362	CNVD
Down syndrome	17334655	CNVD
Neuroticism	17667963	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Autoimmune polyendocrine syndrome	18200029	CNVD
Prostate cancer	19363497	CNVD
Lung cancer	17086460	CNVD
Olfactory neuroblastoma	18408657	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Multiple myeloma	16616336	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21509527	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	17142309	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Ewing''s sarcoma	18628472	CNVD
Leukemia	18628472	CNVD
small cell lung cancer	17426248	CNVD
Developmental delay	21147756	CNVD
Breast cancer	21364760	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Bipolar disorder	19114987	CNVD

Chromatin state (count:51 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:45978400-45994400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr21:45989000-45994200	Weak transcription	Gastric	stomach
3	chr21:45991800-45994400	Enhancers	HepG2	liver
4	chr21:45992200-45994400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
5	chr21:45992600-45994000	Enhancers	Stomach Mucosa	stomach
6	chr21:45992800-45993000	Bivalent Enhancer	Osteobl	bone
7	chr21:45992800-45993200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr21:45993200-45993400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
9	chr21:45993200-45993400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr21:45993200-45993400	Flanking Bivalent TSS/Enh	Duodenum Mucosa	Duodenum
11	chr21:45993200-45993600	Enhancers	Fetal Brain Male	brain
12	chr21:45993400-45994200	Enhancers	Rectal Mucosa Donor 31	rectum
13	chr21:45993400-45994400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
14	chr21:45994200-45994400	Bivalent Enhancer	Duodenum Mucosa	Duodenum
15	chr21:45994200-45994400	Enhancers	Rectal Mucosa Donor 29	rectum
16	chr21:45994200-45994600	Flanking Active TSS	Colonic Mucosa	Colon
17	chr21:45994200-45994600	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
18	chr21:45994200-45994800	Enhancers	Esophagus	oesophagus
19	chr21:45994200-45995000	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
20	chr21:45994200-45995000	Bivalent Enhancer	Fetal Muscle Leg	muscle
21	chr21:45994200-45995000	Enhancers	Gastric	stomach
22	chr21:45994200-45995600	Enhancers	Liver	Liver
23	chr21:45994400-45994600	Enhancers	Primary T killer memory cells from peripheral blood	blood
24	chr21:45994400-45994600	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
25	chr21:45994400-45994600	Bivalent Enhancer	Sigmoid Colon	Sigmoid Colon
26	chr21:45994400-45994600	Flanking Bivalent TSS/Enh	Stomach Mucosa	stomach
27	chr21:45994400-45994800	Flanking Bivalent TSS/Enh	Duodenum Mucosa	Duodenum
28	chr21:45994400-45994800	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
29	chr21:45994400-45995000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
30	chr21:45994400-45995000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
31	chr21:45994400-45995000	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
32	chr21:45994400-45995000	Enhancers	Pancreas	Pancrea
33	chr21:45994400-45995000	Flanking Active TSS	HepG2	liver
34	chr21:45994400-45995200	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr21:45994400-45995200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
36	chr21:45994400-45995400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
37	chr21:45994400-45995400	Enhancers	Spleen	Spleen
38	chr21:45994600-45995000	Active TSS	Rectal Mucosa Donor 31	rectum
39	chr21:45994600-45995200	Bivalent Enhancer	Stomach Mucosa	stomach
40	chr21:45994600-45995400	Enhancers	Colonic Mucosa	Colon
41	chr21:45994600-45995400	Enhancers	Sigmoid Colon	Sigmoid Colon
42	chr21:45994600-46003800	Weak transcription	Primary T killer memory cells from peripheral blood	blood
43	chr21:45994800-45995000	Active TSS	Duodenum Mucosa	Duodenum
44	chr21:45994800-45995000	Bivalent Enhancer	Right Ventricle	heart
45	chr21:45994800-45995800	Enhancers	Rectal Mucosa Donor 29	rectum
46	chr21:45995000-45995600	Enhancers	Duodenum Mucosa	Duodenum
47	chr21:45995000-45995600	Enhancers	HepG2	liver
48	chr21:45995000-45995800	Enhancers	Rectal Mucosa Donor 31	rectum
49	chr21:45995000-45998600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
50	chr21:45995000-45999200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links